| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5578027 | The Journal of Pain | 2017 | 50 Pages |
Abstract
This first in human study on NEO6860, showed that an antagonist of TRPV1, blocking only the activation by capsaicin has been identified. This finding paves the way for the development of a new powerful analgesic for many pain conditions, without the fear of the side effects observed with previous TRPV1 antagonists.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
William Brown, Richard L. Leff, Andrew Griffin, Stuart Hossack, Roxane Aubray, Philippe Walker, Dan A. Chiche,